Is this news to anybody?: A new... - Advanced Prostate...

Advanced Prostate Cancer

22,373 members28,136 posts

Is this news to anybody?

kapakahi profile image
8 Replies

A new treatment for terminal head and neck cancer patients - combining two immunotherapy drugs, nivolumab and ipilimumab. The CheckMate 651 trial, funded by Bristol Myers Squibb - showed especially good results in tumors with high levels of a marker called PD-L1. I don't know that any of this could pertain to APC, but it seems there have been other trials combining these two monoclonal antibody medications in kidney, skin and colon cancers. Seems so simple that something like this has to have been tried with PC, but...maybe there have been other combinations?

theguardian.com/society/2021/oct/11/new-cancer-treatment-destroys-tumours-in-terminally-ill-finds-trial

Written by
kapakahi profile image
kapakahi
To view profiles and participate in discussions please or .
Read more about...
8 Replies
tango65 profile image
tango65

This link has preliminary results of the checkmate 650 trial. It seems to me not very effective in APC and grade 3-4 side effects in about 50% of the patients.

pubmed.ncbi.nlm.nih.gov/329...

More recent data show most patients with APC do not respond to this treatment:

cancernetwork.com/view/nivo...

kapakahi profile image
kapakahi in reply totango65

good to know - thanks

addicted2cycling profile image
addicted2cycling in reply totango65

tango65 wrote --- " ... More recent data show most patients with APC do not respond to this treatment:

cancernetwork.com/view/nivo... "

from above ^^^ " ... Phase 2 data found that the combination of nivolumab plus ipilimumab demonstrated significant anti-tumor activity for patients with mCRPC... "

??? am I reading the mentioned quote wrong ???

tango65 profile image
tango65 in reply toaddicted2cycling

Only 29% of tbe patients have some PSA response. My understsanding is that most of the patients 71% did not responded to the drugs.

kapakahi profile image
kapakahi in reply totango65

I guess I was asking if combinations of other MABs, either one of these with another MAB or two or more entirely different ones, have been tried - I would guess so, but don't know.

tango65 profile image
tango65 in reply tokapakahi

These drugs may have serious side effects,

I think these drugs should be used in cancers which have some genetic alterations which make them susceptible to the drugs, particularly, microsatellite instability-high (MSI-H) or a mismatch repair deficient (dMMR) and/or be PDL-1 positive.

These genetic defects have a low incidence in prostate cancer, so they are doing blind studies combining drugs and most patients do not respond, but about 30% respond.

I was offered one of these trials but I refused because they do not test the genome of the cancer (somatic genome) before accepting the patients.

LeeLiam profile image
LeeLiam

I believe Dr. Onik uses cryo on a tumor then injects the tumor with ipilimumab, pembrolizumab or nivolumab. He seems to have cured metastatic disease in many men. In a study with 19 metastatic men almost half had a complete response and another 1/4 had stable disease; cancerres.aacrjournals.org/...

I thought addicted2cycling had this treatment. a2c, care to comment?

addicted2cycling profile image
addicted2cycling in reply toLeeLiam

LeeLiam wrote --- " ... I thought addicted2cycling had this treatment. a2c, care to comment? "

Yes with cryo + injection in GL10 back in 2015 BUT it was 1st use with degree of my PCa diagnosis AND HAS BEEN MODIFIED (improved) since.

BTW - NO side effects experienced.

Not what you're looking for?

You may also like...

More information on Lu PSMA treatment failure

Comparison of my Axumin and PSMA PET scans had shown high overlap of PSMA and non-PSMA expressing...
Javelin18 profile image

New drug combination attacks prostate cancer on two fronts to keep men healthy for longer

https://www.icr.ac.uk/news-archive/new-drug-combination-attacks-prostate-cancer-on-two-fronts-to-kee
dexy1234 profile image

Cancer BREAKTHROUGH: Revolutionary way to target tumours - 70% success rate BRITISH cancer doctors are to trial a revolutionary radiotherapy

The study into the alpha radiation treatment follows the success of trials on 26 skin cancer...
George71 profile image

Insurance dilemma and Medicare.

I recently turned 66. I've been in this battle for nearly two years now. Before that, I lost my job...
RalphieJr64 profile image

Undecided on ADT

Well, I have not searched about this for long, but while I wait to see if estrogen patches will be...
Maxone73 profile image

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.